Cash flow AXA

Equities

CS

FR0000120628

Life & Health Insurance

Market Closed - Euronext Paris Other stock markets 03:55:00 17/01/26 am AEDT			5-day change	1st Jan Change
39.27 ^EUR	-0.23%		-1.80%	-4.13%

16/01	Berenberg Tweaks AXA Forecasts on Expected Boost from Prima Deal	MT
16/01	AXA : Berenberg maintains a Buy rating	ZD

1e.4WnLuGsWg6akZURg9PqBfHqij3naMRb_uSojixul374.2TbzjgNl-__LPQYImcj5UQzl2iPqRSad10kS7yrs7tmNBKCOX1zk088TEQ

Published financial data: AXA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Premiums and Annuity Revenues	93.58B	96.32B	99.29B	80.89B	86.08B
Total Interest And Dividend Income	12.17B	12.16B	12.2B	-2.16B	-3.74B
Gain (Loss) on Sale of Investments, Total (Rev)	3.78B	10.58B	-10.72B	5.68B	7.69B
Non-Insurance Activities Revenues	486M	535M	237M	-	-
Other Revenues, Total	2.32B	2.57B	2.69B	2.74B	1.22B
Total Revenues	112B	122B	104B	87.15B	91.26B
Policy Benefits	83.61B	88.43B	71.43B	73.96B	78.03B
Policy Acquisition / Underwriting Costs, Total	12.63B	13.05B	12.76B	-	-
Amortization of Goodwill and Intangible Assets - (IS)	110M	41M	135M	-	-
Selling General & Admin Expenses, Total	10.72B	10.39B	10.36B	-	-
Other Operating Expenses	-251M	461M	-348M	3.94B	2.78B
Non-Insurance Activities Expenses	79M	63M	13M	-	-
Total Operating Expenses	107B	112B	94.36B	77.9B	80.81B
Operating Income	5.44B	9.73B	9.34B	9.26B	10.45B
Interest Expense, Total	-878M	-462M	-477M	-609M	-607M
Income (Loss) on Equity Invest.	400M	144M	-141M	277M	173M
Other Non Operating Income (Expenses)	-3M	0	2M	1M	1M
EBT, Excl. Unusual Items	4.96B	9.42B	8.72B	8.92B	10.01B
Impairment of Goodwill	-28M	-	-	-	-
Asset Writedown	-64M	-218M	7M	-1M	-
Other Unusual Items	-	-	-19M	-37M	-36M
EBT, Incl. Unusual Items	4.87B	9.2B	8.71B	8.89B	9.98B
Income Tax Expense	1.54B	1.69B	1.86B	1.51B	2.46B
Earnings From Continuing Operations	3.33B	7.51B	6.86B	7.37B	7.52B
Earnings Of Discontinued Operations	-	-	-	-	555M
Net Income to Company	3.33B	7.51B	6.86B	7.37B	8.07B
Minority Interest	-167M	-214M	-180M	-184M	-188M
Net Income - (IS)	3.16B	7.29B	6.68B	7.19B	7.89B
Preferred Dividend and Other Adjustments	177M	194M	182M	185M	201M
Net Income to Common Incl Extra Items	2.99B	7.1B	6.49B	7B	7.68B
Net Income to Common Excl. Extra Items	2.99B	7.1B	6.49B	7B	7.13B
Per Share Items
Net EPS - Basic	1.25	2.98	2.84	3.14	3.51
Basic EPS - Continuing Operations	1.25	2.98	2.84	3.14	3.25
Basic Weighted Average Shares Outstanding	2.38B	2.38B	2.29B	2.23B	2.19B
Net EPS - Diluted	1.25	2.97	2.83	3.13	3.5
Diluted EPS - Continuing Operations	1.25	2.97	2.83	3.13	3.25
Diluted Weighted Average Shares Outstanding	2.39B	2.39B	2.3B	2.24B	2.2B
Normalized Basic EPS	1.23	2.38	2.3	2.42	2.77
Normalized Diluted EPS	1.23	2.37	2.29	2.41	2.76
Dividend Per Share	1.43	1.54	1.7	1.98	2.15
Payout Ratio	55.09	47.83	59.42	58.39	60.35
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	6.62B	10.6B	10.21B	-	-
EBITA	5.62B	9.98B	9.47B	9.37B	10.58B
EBIT	5.44B	9.73B	9.34B	9.26B	10.45B
Effective Tax Rate - (Ratio)	31.63	18.36	21.3	17.03	24.64
Current Domestic Taxes	-	-	-	-	-
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	1.43B	1.39B	1.67B	1.26B	1.72B
Deferred Domestic Taxes	-	-	-	-	-
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	110M	301M	186M	255M	739M
Normalized Net Income	2.94B	5.67B	5.27B	5.39B	6.07B
Non-Cash Pension Expense	27M	30M	17M	91M	57M
Supplemental Operating Expense Items
General and Administrative Expenses	10.72B	10.39B	10.36B	-	-
Stock-Based Comp., Other (Total)	165M	192M	180M	198M	244M
Total Stock-Based Compensation	165M	192M	180M	198M	244M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Investment In Debt Securities	429B	397B	302B	298B	316B
Investment In Equity and Preferred Securities, Total	33.34B	38.82B	32.18B	15.18B	15.72B
Trading Asset Securities, Total	319M	1M	4M	49.19B	48.86B
Real Estate Owned	30.29B	31.02B	31.73B	32.54B	32B
Mortgage Loans	-	-	-	-	-
Total Other Investments	31.2B	36.76B	39B	22.09B	27.31B
Total investments	524B	504B	405B	417B	439B
Cash And Equivalents	28.24B	25.05B	26.16B	24.97B	18.99B
Reinsurance Recoverable - (IS)	30.89B	41.12B	45.52B	25.21B	26.08B
Other Receivables - (Insurance Template)	61.18B	60.89B	64.26B	37.82B	35.11B
Deferred Policy Acquisition Costs - (BS)	16.53B	17.82B	26.3B	-	-
Separate Account Assets	77.8B	86.32B	76.47B	82.75B	90.1B
Net Property Plant And Equipment	2.65B	2.44B	2.23B	2.1B	2.21B
Goodwill	16.58B	17.17B	17.75B	17.86B	18.14B
Other Intangibles, Total	4.43B	4.3B	4.29B	4.22B	4.02B
Other Current Assets, Total	38.96B	13.47B	21.36B	26.22B	13.41B
Deferred Tax Assets Long-Term (Collected)	333M	421M	4.15B	3.48B	3.36B
Deferred Charges Long-Term	-	-	-	407M	406M
Other Long-Term Assets, Total	2.72B	2.51B	2.9B	2.49B	2.49B
Total Assets	805B	775B	697B	644B	654B
Liabilities
Accrued Expenses, Total	81M	93M	95M	84M	89M
Insurance And Annuity Liabilities	368B	356B	306B	457B	477B
Unpaid Claims	98.44B	104B	109B	-	-
Unearned Premiums	22.98B	23.92B	24.68B	-	-
Reinsurance Payable - (BS)	14.08B	16.47B	16.92B	8M	6M
Current Portion of Long-Term Debt	33.96B	29.54B	32.62B	34.48B	36.78B
Short-Term Borrowings	1.52B	1.18B	984M	994M	798M
Long-Term Debt	30.12B	30.47B	29.79B	24.07B	24.57B
Long-Term Leases	-	-	-	-	-
Separate Account Liability	78.08B	86.36B	76.72B	12.11B	12.57B
Current Income Taxes Payable	1.09B	924M	1.26B	1.28B	1.29B
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	40.99B	16.35B	19.95B	33.91B	20.4B
Pension & Other Post Retirement Benefits	8.45B	7.48B	4.57B	3.52B	3.25B
Deferred Tax Liability Non-Current	6.47B	5.33B	1.43B	1.74B	1.98B
Other Non Current Liabilities	14.69B	14.21B	17.16B	15.38B	14.38B
Total Liabilities	719B	693B	642B	584B	593B
Common Stock, Total	5.54B	5.54B	5.39B	22.13B	20.28B
Additional Paid In Capital	21.74B	21.8B	20.16B	-	-
Retained Earnings	20.28B	24.7B	28.18B	33.14B	36.48B
Treasury Stock	-744M	-1.63B	-2.15B	-	-
Comprehensive Income and Other	24.81B	20.72B	-6.22B	-5.69B	-6.82B
Total Common Equity	71.61B	71.14B	45.35B	49.58B	49.94B
Minority Interest	13.79B	11.84B	9.42B	10.41B	10.68B
Total Equity	85.4B	82.98B	54.78B	59.99B	60.62B
Total Liabilities And Equity	805B	775B	697B	644B	654B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.39B	2.36B	2.26B	2.23B	2.18B
ECS Total Common Shares Outstanding	2.39B	2.36B	2.26B	2.23B	2.18B
Book Value / Share	30.01	30.2	20.03	22.27	22.96
Tangible Book Value	50.6B	49.67B	23.31B	27.5B	27.78B
Tangible Book Value Per Share	21.21	21.09	10.29	12.35	12.77
Total Debt	65.59B	61.2B	63.39B	59.54B	62.14B
Net Debt	37.35B	36.15B	37.23B	34.57B	43.15B
Debt Equivalent of Unfunded Proj. Benefit Obligation	6.74B	5.48B	1.44B	655M	632M
Minority Interest, Total (Incl. Fin. Div)	13.79B	11.84B	9.42B	10.41B	10.68B
Equity Method Investments, Total	2.47B	2.6B	2.43B	1.94B	1.53B
Account Code - Inventory Valuation	3	3	3	3	3
Full Time Employees	110K	106K	92.7K	94.7K	100K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	3.16B	7.29B	6.68B	7.19B	7.89B
Depreciation, Depletion & Amortization	1.01B	624M	-293M	-674M	-693M
Amortization of Goodwill and Intangible Assets - (CF)	170M	246M	130M	112M	131M
Total Depreciation, Depletion & Amortization	1.18B	870M	-163M	-562M	-562M
(Gain) Loss on Sale of Investments - (CF)	-3.76B	-10.64B	10.68B	3.34B	-7.48B
Total Asset Writedown	87M	212M	-	-9.03B	-
(Income) Loss On Equity Investments - (CF)	-400M	-144M	152M	-277M	-173M
Change in Accounts Receivable	9.47B	4.34B	956M	4.91B	14.87B
Change in Other Net Operating Assets (Collected)	908M	-1.81B	-1.58B	-1.14B	-95M
Net Cash From Discontinued Operations	-	-	-	-	-589M
Other Operating Activities	14.89B	6.4B	-8.83B	2.01B	-1.98B
Cash from Operations	25.53B	6.53B	7.88B	6.44B	11.88B
Capital Expenditure	-389M	-350M	-353M	-427M	-476M
Sale of Property, Plant, and Equipment	3M	6M	33M	21M	17M
Cash Acquisitions	-18M	24M	-34M	-809M	-53M
Divestitures	888M	-1.11B	315M	-46M	194M
Sale (Purchase) of Real Estate Properties (Collected)	-2.06B	-2.19B	-622M	28M	262M
Investment in Marketable and Equity Securities, Total	-6.66B	4.76B	9.18B	5.32B	-8.55B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-2.49B	-7.26B	-8.08B	-4.03B	-4.1B
Other Investing Activities, Total	-707M	-2.83B	36M	-1.66B	1.46B
Cash from Investing	-11.43B	-8.95B	470M	-1.6B	-11.25B
Long-Term Debt Issued, Total	-	1.02B	3.36B	1.75B	776M
Total Debt Issued	-	1.02B	3.36B	1.75B	776M
Long-Term Debt Repaid, Total	-1.82B	-116M	-1.54B	-1.94B	-
Total Debt Repaid	-1.82B	-116M	-1.54B	-1.94B	-
Issuance of Common Stock	71M	279M	335M	362M	1.99B
Repurchase of Common Stock	-280M	-1.31B	-3.99B	-2.15B	-4.74B
Common Dividends Paid	-1.74B	-3.49B	-3.97B	-4.2B	-4.76B
Common & Preferred Stock Dividends Paid	-1.74B	-3.49B	-3.97B	-4.2B	-4.76B
Other Financing Activities, Total	-1.16B	-720M	-329M	-599M	-598M
Cash from Financing	-4.93B	-4.33B	-6.12B	-6.78B	-7.34B
Foreign Exchange Rate Adjustments	-737M	202M	-430M	-151M	280M
Miscellaneous Cash Flow Adjustments	-2.9B	3.41B	-489M	539M	-
Net Change in Cash	5.54B	-3.14B	1.31B	-1.55B	-6.43B
Supplemental Items
Cash Interest Paid	1.16B	718M	329M	5.36B	5.96B
Cash Income Tax Paid (Refund)	1.36B	1.53B	1.34B	1.08B	1.82B
Net Debt Issued / Repaid	-1.82B	906M	1.82B	-194M	776M
Levered Free Cash Flow	2.69B	6.4B	2.33B	3.04B	5B
Unlevered Free Cash Flow	3.24B	6.69B	2.63B	3.42B	5.38B
Change In Net Working Capital	1.12B	104M	2.87B	1.57B	353M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	0.43	0.77	0.79	0.9	1.01
Return on Total Capital	2.32	4.12	4.45	4.85	5.39
Return On Equity %	3.95	8.92	9.95	12.77	12.47
Return on Common Equity	4.22	9.95	11.15	14.64	14.33
Margin Analysis
Gross Profit Margin %	14.26	16.88	18.79	15.14	14.49
SG&A Margin	9.54	8.5	10	-	-
EBITDA Margin %	5.89	8.68	9.84	-	-
EBITA Margin %	5	8.17	9.13	10.75	11.59
EBIT Margin %	4.85	7.97	9	10.62	11.45
Income From Continuing Operations Margin %	2.96	6.15	6.61	8.46	8.24
Net Income Margin %	2.82	5.97	6.44	8.25	8.64
Net Avail. For Common Margin %	2.66	5.81	6.26	8.04	7.81
Normalized Net Income Margin	2.61	4.64	5.08	6.19	6.65
Levered Free Cash Flow Margin	2.4	5.24	2.25	3.49	5.48
Unlevered Free Cash Flow Margin	2.88	5.48	2.53	3.92	5.9
Asset Turnover
Asset Turnover	0.14	0.15	0.14	0.14	0.14
Fixed Assets Turnover	40.69	47.99	44.37	40.29	42.38
Receivables Turnover (Average Receivables)	4.89	5.13	5.17	10.5K	10.29K
Short Term Liquidity
Current Ratio	0.6	0.56	0.59	1.89	1.93
Quick Ratio	0.27	0.28	0.27	1.16	1.26
Operating Cash Flow to Current Liabilities	0.12	0.03	0.04	0.09	0.2
Days Sales Outstanding (Average Receivables)	74.83	71.09	70.57	0.03	0.04
Average Days Payable Outstanding	419.24	418.37	534.28	0.03	0.03
Long Term Solvency
Total Debt/Equity	76.81	73.75	115.73	99.25	102.5
Total Debt / Total Capital	43.44	42.45	53.65	49.81	50.62
LT Debt/Equity	35.27	36.72	54.39	40.12	40.52
Long-Term Debt / Total Capital	19.95	21.14	25.21	20.14	20.01
Total Liabilities / Total Assets	89.39	89.3	92.14	90.69	90.73
EBIT / Interest Expense	6.2	21.07	19.58	15.2	17.21
EBITDA / Interest Expense	7.54	22.95	21.4	-	-
(EBITDA - Capex) / Interest Expense	7.1	22.19	20.66	-	-
Total Debt / EBITDA	9.91	5.77	6.21	-	-
Net Debt / EBITDA	5.64	3.41	3.65	-	-
Total Debt / (EBITDA - Capex)	10.52	5.97	6.43	-	-
Net Debt / (EBITDA - Capex)	5.99	3.53	3.78	-	-
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-15.6	8.74	-15.12	0.41	6.46
Gross Profit, 1 Yr. Growth %	-7.47	28.72	-5.48	17.22	12.44
EBITDA, 1 Yr. Growth %	-9.7	60.14	-3.73	-	-
EBITA, 1 Yr. Growth %	-7.98	77.72	-5.12	24.12	17.89
EBIT, 1 Yr. Growth %	-8.58	78.75	-4.06	24.8	18.23
Earnings From Cont. Operations, 1 Yr. Growth %	-20.8	125.4	-8.7	41.6	6.86
Net Income, 1 Yr. Growth %	-17.97	130.53	-8.49	42.05	9.7
Normalized Net Income, 1 Yr. Growth %	-10.02	93.17	-7.04	35.23	18.76
Diluted EPS Before Extra, 1 Yr. Growth %	-17.77	137.6	-4.71	47.64	8.99
Net Property, Plant and Equip., 1 Yr. Growth %	-7.8	-7.78	-8.68	-6.1	5.58
Accounts Receivable, 1 Yr. Growth %	-3.27	-1.21	4.73	175	-54.55
Total Assets, 1 Yr. Growth %	3.04	-3.62	-10.16	0.95	1.46
Common Equity, 1 Yr. Growth %	2.45	-0.66	-36.24	7.61	0.73
Tangible Book Value, 1 Yr. Growth %	7.09	-1.83	-53.08	14.34	1.03
Cash From Operations, 1 Yr. Growth %	189.27	-74.44	20.76	-26.05	197.54
Capital Expenditures, 1 Yr. Growth %	-15.8	-10.03	0.86	7.29	13.6
Levered Free Cash Flow, 1 Yr. Growth %	3.86	137.88	-63.61	-102.06	85.8
Unlevered Free Cash Flow, 1 Yr. Growth %	6.54	106.51	-60.72	-102.33	75.06
Dividend Per Share, 1 Yr. Growth %	95.89	7.69	10.39	16.47	8.59
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.74	-4.2	-3.93	-15.54	2.54
Gross Profit, 2 Yr. CAGR %	-8.96	9.13	10.3	-20.01	8.39
EBITDA, 2 Yr. CAGR %	-14.15	20.26	24.17	-	-
EBITA, 2 Yr. CAGR %	-17.52	27.88	29.85	-3.12	18.39
EBIT, 2 Yr. CAGR %	-18.19	27.83	30.96	-2.49	18.69
Earnings From Cont. Operations, 2 Yr. CAGR %	678.23	33.61	43.46	-0.9	20.17
Net Income, 2 Yr. CAGR %	21.59	37.52	45.25	-0.72	24.83
Normalized Net Income, 2 Yr. CAGR %	-37.12	31.83	34	-2.47	23.37
Diluted EPS Before Extra, 2 Yr. CAGR %	13.65	39.78	50.47	2.66	23.77
Net Property, Plant and Equip., 2 Yr. CAGR %	28.71	-7.79	-8.23	-7.4	-0.43
Accounts Receivable, 2 Yr. CAGR %	3.29	-2.25	1.72	-97.72	11.8
Total Assets, 2 Yr. CAGR %	-7.02	-0.35	-6.95	-8.84	1.2
Common Equity, 2 Yr. CAGR %	7.1	0.88	-20.42	-16.52	4.12
Tangible Book Value, 2 Yr. CAGR %	11.61	2.53	-32.13	-25.59	7.48
Cash From Operations, 2 Yr. CAGR %	82.89	-14.02	-44.44	-0.68	16.81
Capital Expenditures, 2 Yr. CAGR %	-8.24	-12.96	-4.74	10.45	9.36
Levered Free Cash Flow, 2 Yr. CAGR %	-69.67	57.18	-6.95	-31.11	-81.58
Unlevered Free Cash Flow, 2 Yr. CAGR %	-66.92	48.32	-9.94	-28.51	-80.87
Dividend Per Share, 2 Yr. CAGR %	3.3	45.24	9.03	13.39	12.46
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-5.37	4.71	-7.99	-8.12	-9.27
Gross Profit, 3 Yr. CAGR %	-4.62	2.18	4.03	-6.26	-13.77
EBITDA, 3 Yr. CAGR %	-6.73	5.68	11.66	-	-
EBITA, 3 Yr. CAGR %	-10.51	6.53	15.77	18.6	1.96
EBIT, 3 Yr. CAGR %	-11.02	6.16	16.17	19.34	2.39
Earnings From Cont. Operations, 3 Yr. CAGR %	-20.39	414.9	17.68	30.32	0.05
Net Income, 3 Yr. CAGR %	-20.13	50.49	20.06	31.47	2.64
Normalized Net Income, 3 Yr. CAGR %	-12.68	-8.6	17.34	22.48	2.3
Diluted EPS Before Extra, 3 Yr. CAGR %	-20.52	45.33	23.02	35.79	3.02
Net Property, Plant and Equip., 3 Yr. CAGR %	24.28	15.18	-8.08	-7.52	-3.26
Accounts Receivable, 3 Yr. CAGR %	16.52	1.76	0.03	-91.99	-93.82
Total Assets, 3 Yr. CAGR %	-2.58	-5.9	-3.73	-7.13	-5.53
Common Equity, 3 Yr. CAGR %	0.95	4.45	-13.43	-11.53	-11.12
Tangible Book Value, 3 Yr. CAGR %	-0.3	6.94	-20.99	-18.39	-17.6
Cash From Operations, 3 Yr. CAGR %	15.61	-5.09	-3.71	-36.83	22.1
Capital Expenditures, 3 Yr. CAGR %	-0.34	-8.84	-8.58	3.16	10.79
Levered Free Cash Flow, 3 Yr. CAGR %	-32.95	-39.74	-3.48	4.13	-7.89
Unlevered Free Cash Flow, 3 Yr. CAGR %	-29.19	-39.09	-4.75	1.81	-7
Dividend Per Share, 3 Yr. CAGR %	4.31	4.75	32.55	11.46	11.76
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.54	-0.78	-4.8	-3.92	-7.27
Gross Profit, 5 Yr. CAGR %	-3	1.19	1.09	-7.35	-5.25
EBITDA, 5 Yr. CAGR %	-5.51	1.54	4.58	-	-
EBITA, 5 Yr. CAGR %	-7.09	1.5	3.86	2.56	11.63
EBIT, 5 Yr. CAGR %	-7.39	1.24	3.85	2.61	11.89
Earnings From Cont. Operations, 5 Yr. CAGR %	-10.87	2.51	0.75	166.35	12.32
Net Income, 5 Yr. CAGR %	-10.84	4.59	1.46	27.42	15.38
Normalized Net Income, 5 Yr. CAGR %	-8	1.34	3.63	-6.19	13.22
Diluted EPS Before Extra, 5 Yr. CAGR %	-10.28	3.67	2.59	26.46	16.4
Net Property, Plant and Equip., 5 Yr. CAGR %	13.09	10.06	10.08	5.55	-5.09
Accounts Receivable, 5 Yr. CAGR %	10.16	10.48	10.36	-77.72	-81.34
Total Assets, 5 Yr. CAGR %	-1.93	-2.78	-4.35	-7.09	-3.49
Common Equity, 5 Yr. CAGR %	0.9	0.15	-8.21	-4.5	-6.5
Tangible Book Value, 5 Yr. CAGR %	1	-0.39	-14.51	-7.5	-10.07
Cash From Operations, 5 Yr. CAGR %	6.98	-13.58	-13.76	-3.35	6.12
Capital Expenditures, 5 Yr. CAGR %	-3.38	-5.81	-2.12	-1.56	0.6
Levered Free Cash Flow, 5 Yr. CAGR %	-0.92	30.99	-23.56	-36.42	14.06
Unlevered Free Cash Flow, 5 Yr. CAGR %	0.74	29.39	-22.04	-35.06	12.09
Dividend Per Share, 5 Yr. CAGR %	5.39	5.83	6.17	8.12	24.11